Nova EYE Medical Limited (ASX: EYE)
Sector: Health Care
Market cap: A$43M (as of 2 Nov 2026)
Medical devices manufacturer.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 27 Aug 2025 | HSBC Custody Nominees (Australia) Limited | Entry | ?% → 18.48% | Filing ↗ |
| 11 Feb 2025 | NATIONAL NOMINEES LIMITED | Decrease | 17.530% → 15.240% | Filing ↗ |
| 26 Aug 2024 | NATIONAL NOMINEES LIMITED | Entry | ?% → 17.51% | Filing ↗ |
| 19 Mar 2024 | Jencay Capital Pty Limited | Exit | — | Filing ↗ |
| 19 Mar 2024 | NATIONAL NOMINEES LIMITED | Decrease | 19.200% → 17.530% | Filing ↗ |
Director trades — on-market
Latest guidance
| Date | Period | Guidance | Source |
|---|---|---|---|
| 29 Apr 2025 | FY25 | The glaucoma segment is expected to achieve profitability in H2FY25, although the level of Q4FY25 sales to China may impact the operating result. | Filing ↗ |
Ask about EYE in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has EYE raised money in the last year, and at what discount?
- What was EYE's latest cash position and runway?
Loading EYE…